bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 43.1% in February

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 154,600 shares, a growth of 43.1% from the February 13th total of 108,000 shares. Based on an average trading volume of 1,300 shares, the days-to-cover ratio is presently 118.9 days. Currently, 0.1% of the company's shares are sold short.

bioMérieux Price Performance

Shares of OTCMKTS:BMXMF remained flat at $126.40 during midday trading on Thursday. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. bioMérieux has a 1 year low of $93.50 and a 1 year high of $126.64. The firm has a 50-day moving average of $118.73 and a 200-day moving average of $113.51.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.